Depreciation of Organogenesis Holdings Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Organogenesis Holdings Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Organogenesis Holdings Inc. Depreciation for the quarter ending 31 Dec 2025 was $4,066,000, a 12% increase year-over-year.
  • Organogenesis Holdings Inc. Depreciation for the twelve months ending 31 Dec 2025 was $15,273,000, a 12% increase year-over-year.
  • Organogenesis Holdings Inc. annual Depreciation for 2025 was $15,273,000, a 12% increase from 2024.
  • Organogenesis Holdings Inc. annual Depreciation for 2024 was $13,623,000, a 30% increase from 2023.
  • Organogenesis Holdings Inc. annual Depreciation for 2023 was $10,448,000, a 79% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Organogenesis Holdings Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $15,273,000 $4,066,000 +$451,000 +12% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $14,822,000 $4,029,000 +$459,000 +13% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $14,363,000 $3,734,000 +$368,000 +11% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $13,995,000 $3,444,000 +$372,000 +12% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $13,623,000 $3,615,000 +$633,000 +21% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $12,990,000 $3,570,000 +$1,026,000 +40% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $11,964,000 $3,366,000 +$1,138,000 +51% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $10,826,000 $3,072,000 +$378,000 +14% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $10,448,000 $2,982,000 +$1,468,000 +97% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $8,980,000 $2,544,000 +$1,088,000 +75% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $7,892,000 $2,228,000 +$700,000 +46% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $7,192,000 $2,694,000 +$1,347,000 +100% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $5,845,000 $1,514,000 -$257,000 -15% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $6,102,000 $1,456,000 -$481,000 -25% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $6,583,000 $1,528,000 +$465,000 +44% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $6,118,000 $1,347,000 +$337,000 +33% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $5,781,000 $1,771,000 +$261,000 +17% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $5,520,000 $1,937,000 +$802,000 +71% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $4,718,000 $1,063,000 +$172,000 +19% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $4,546,000 $1,010,000 +$108,000 +12% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $4,438,000 $1,510,000 +$280,000 +23% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $4,158,000 $1,135,000 +$343,000 +43% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $3,815,000 $891,000 +$32,000 +3.7% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $3,783,000 $902,000 $0 0% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q4 2019 $3,783,000 $1,230,000 +$529,000 +75% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $3,254,000 $792,000 -$69,000 -8% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $3,323,000 $859,000 -$16,000 -1.8% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $3,339,000 $902,000 +$30,000 +3.4% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $3,309,000 $701,000 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2021 2020 FY
Q3 2018 $861,000 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $875,000 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $872,000 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1

Organogenesis Holdings Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $15,273,000 +$1,650,000 +12% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $13,623,000 +$3,175,000 +30% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $10,448,000 +$4,603,000 +79% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $5,845,000 +$64,000 +1.1% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $5,781,000 +$1,343,000 +30% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $4,438,000 +$655,000 +17% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $3,783,000 +$474,000 +14% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $3,309,000 -$282,000 -7.9% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2021 2020 FY
2017 $3,591,000 -$2,111,000 -37% 01 Jan 2017 31 Dec 2017 10-K 09 Mar 2020 2019 FY
2016 $5,702,000 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.